Adarza BioSystems, Inc.

Adarza’s ZIVA technology platform enables highly multiplexed label-free detection of serum analytes.

Founded 2008

Maryland Heights, United States 8 employees Series D Total: $64.15M Biotechnology, Health Care

Adarza BioSystems, Inc. is a pioneering player in the biotechnology and healthcare industries, based in the United States. The company's innovative ZIVA technology platform, powered by Arrayed Imaging Reflectometry (AIR), allows for label-free detection of serum analytes with unparalleled precision and robustness. Adarza's groundbreaking platform boasts the capability to simultaneously detect hundreds of analytes in a single fluid sample, setting new industry standards in terms of multiplexing, sensitivity, and specificity. This technology not only offers flexibility and rich data but also covers the entire companion diagnostic life cycle, from discovery to clinic, catering to high-throughput core facilities and point of care settings. Furthermore, Adarza's pioneering antibody chips, with their high-multiplex and sensitivity, are poised to disrupt the field of proteomics research much like the first gene-chips revolutionized genomics analysis. The company's remarkable progress culminated in a significant $25.00M Series D investment on 04 February 2020, with participation from investors including Excell Partners, Lightchain, and 3×5 Partners. In summary, Adarza BioSystems, Inc. has proven itself as a trailblazer in the biotechnology space, combining cutting-edge technology with substantial financial backing. The company's ability to deliver industry-leading precision, accuracy, and robustness positions it as a compelling investment opportunity within the rapidly evolving landscape of healthcare and biotechnology.

Funding Stage	Amount	Investors	Lead Investors	Date
Series D	$25.00M	3	Excell Partners, Lightchain +1	04 Feb 2020
Venture Round	$10.85M	-		16 Jan 2018
Series C	$17.00M	6	Lewis & Clark Ventures, Serra Ventures +4	19 Jan 2017
Series B	$5.00M	4	Cultivation Capital, Lewis & Clark Ventures +2	21 Mar 2016
Series A	$4.00M	3	Cultivation Capital, Next47 +1	02 Oct 2014
Series A	$2.00M	2	Cultivation Capital, Serra Ventures	09 Jul 2014
Seed Round	$250.00K	1	Missouri Technology Corporation (MTC)	18 Jul 2013
Grant	$50.00K	1	Arch Grants	14 May 2013
Seed Round	Undisclosed	2	BioGenerator, St. Louis Arch Angels	17 Apr 2013

Funding Stage

Amount

Investors

Lead Investors

Date

Series D

$25.00M

Excell Partners, Lightchain +1

04 Feb 2020

Venture Round

$10.85M

16 Jan 2018

Series C

$17.00M

Lewis & Clark Ventures, Serra Ventures +4

19 Jan 2017

Series B

$5.00M

Cultivation Capital, Lewis & Clark Ventures +2

21 Mar 2016

Series A

$4.00M

Cultivation Capital, Next47 +1

02 Oct 2014

Series A

$2.00M

Cultivation Capital, Serra Ventures

09 Jul 2014

Seed Round

$250.00K

Missouri Technology Corporation (MTC)

18 Jul 2013

Grant

$50.00K

Arch Grants

14 May 2013

Seed Round

Undisclosed

BioGenerator, St. Louis Arch Angels

17 Apr 2013

FAQ About Adarza BioSystems, Inc.

Adarza’s ZIVA technology platform enables highly multiplexed label-free detection of serum analytes.

Adarza BioSystems, Inc. was founded in 2008.

Adarza BioSystems, Inc. is headquartered in Maryland Heights, United States.

Adarza BioSystems, Inc. operates in Biotechnology and Health Care. Its work centres on medical diagnostics, label-free detection, proteomics research and high-throughput core facilities.

Adarza BioSystems, Inc. has approximately 8 employees.

Adarza BioSystems, Inc. has completed 9 funding rounds, raising a total of $64.15M. The latest funding stage is Series D.

Top alternatives and competitors to Adarza BioSystems, Inc. include HAWK Biosystems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Adarza BioSystems, Inc. and HAWK Biosystems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Adarza BioSystems, Inc.

Funding Rounds & Investors (9)

Adarza BioSystems, Inc. Alternatives & Competitors

FAQ About Adarza BioSystems, Inc.